2018 Pan Pacific Lymphoma Conference
S

Beyond Checkpoint Inhibitors for Hodgkin Lymphoma

By 2018 Pan Pacific Lymphoma Conference FEATURING Stephen M. Ansell
08/2018
0 Comments
Login to view comments. Click here to Login

Related Content

AUTOPLAY
Scripps MD Anderson Cancer Center

7th Annual Scripps Cancer Care Symposium

Fri, Oct 11, 2019
Society of Hematologic Oncology Seventh Annual Meeting (SOHO 2019)

Society of Hematologic Oncology Seventh Annual Meeting (SOHO 2019)

Wed, Sep 11, 2019
Eurasian Hematology-Oncology Group

Xth Eurasian Hematology-Oncology Congress

Tue, Oct 8, 2019
16:04
2018 Pan Pacific Lymphoma Conference

Beyond Standard Chemotherapy Novel Agents and Appraoches in HL

Feat. B. Pro
09:60
2018 Pan Pacific Lymphoma Conference

The Tumor Microenvironment Using Immune Checkpoint Inhibitors

Feat. J. Gribben
12:43
Loretta Nastoupil

Checkpoint Inhibitors in Hodgkin Lymphoma: When and How

24:36
Stephen M. Ansell

Hodgkin Lymphoma - Immunotherapy

11:53
Indy Hematology Review

Hodgkin Lymphoma - Revolutionized Treatment Options Using Brentuximab Ve...

Feat. B. Cheson
12:32
Indy Hematology Review

Emerging Strategies and Treatment in Hodgkin Lymphoma

Feat. B. Cheson
05:17
Loretta Nastoupil

Combination Immunotherapy for Checkpoint Inhibitors in Lymphoma Immunoth...

24:23
Cleveland Clinic Orthopaedic & Rheumatologic Institute

Autoimmune Complications from Cancer Chemotherapy: An Emerging Field

Feat. L. Cappelli
27:01
Craig Moskowitz

Hodgkin Lymphoma - Metabolic Tumor Volume as Prognostic Factor, Role of ...

08:17
2018 Pan Pacific Lymphoma Conference

How Can We Activate the Anti-tumor Immune Response in Lymphoma?

Feat. S. Ansell
15:08
2018 Pan Pacific Lymphoma Conference

Immune Evasion and Engagement in Lymphoma: The Mechanisms of Impairment ...

Feat. S. Ansell
15:22
Scripps Cancer Center's 39th Annual Conference: Clinical Hematology & Oncology 2019

Relapsed/Refractory Hodgkin Lymphoma - Salvage Treatments, Nivolumab and...

Feat. J. Svoboda
6:45
2018 Pan Pacific Lymphoma Conference

Hodgkin Lymphoma: First Relapse Options

Feat. B. Pro
9:60
2018 Pan Pacific Lymphoma Conference

Relapsed and Primary Refractory Hodgkin Lymphoma in the Near Future

Feat. C. Moskowitz
17:13
Catherine Diefenbach

Beyond transplant: Relapsed and Refractory Hodgkin Lymphoma

15:48
2018 Pan Pacific Lymphoma Conference

Evalutation of patients for ASCT in Relapsed Refractory Hodgkin Lymphoma

Feat. C. Moskowitz
09:35
Catherine Diefenbach

Immunotherapy in Relapsed Refractory Hodgkin Lymphoma

07:11
Society of Hematologic Oncology Sixth Annual Meeting

Oral Abstract SCT 020: Incidence, Risk Factors and Treatment Response in...

Feat. D. Rivera
20:26
2018 Pan Pacific Lymphoma Conference

Radiation Therapy for nondular lymphocyte predominant Hodgkin Lymphoma

Feat. R. Hoppe
39:10
ESO Lymphoma Course

Hodgkin Lymphoma - Kairos vs. Chronos Principle & New Active Agents (Ant...

Feat. P. Johnson